Skip to main content
Log in

Nonsecretion of myeloma protein in spite of an increase in tumor burden by chemotherapy

  • Case Report
  • Published:
Annals of Hematology Aims and scope Submit manuscript

Summary

A unique case of IgA κ myeloma is presented. While the myeloma cells had secreted a large quantity of IgA κ monoclonal protein, they were induced to stop secreting the monoclonal protein by cyclophosphamide and vincristine, in spite of a remarkable increase in tumor burden. The absence of intracytoplasmic IgAκ was clearly evidenced by the immunofluorescence technique using anti-IgA and anti-κ monoclonal antibodies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Durie BGM, Salmon SE (1975) A clinical staging system for multiple myeloma. Cancer 36: 842–854

    Google Scholar 

  2. Greipp PR, Raymond NM, Kyle RA, O'Fallon WM (1985) Multiple myeloma: significance of plasmablastic subtype in morphological classification. Blood 65: 305–310

    Google Scholar 

  3. Michot F (1968) Beitrag zum Problem des Plasmozytoms ohne Paraproteine. Dtsch Med Wochenschr 93: 2072–2075

    Google Scholar 

  4. Sahasrabudhe DM, Parker JC (1981) Decreasing M spike with increasing tumor burden in multiple myeloma. Arch Int Med 141: 1152–1153

    Google Scholar 

  5. Tamura J, Kurabayashi H, Sawamura M, Murakami H, Nogiwa E, Shinonome S, Miyawaki S, Kubota K, Sato S, Omine M, Naruse T, Tsuchiya J, Shirakura T (1989) Clinical features of common acute lymphoblastic leukemia antigen (CALLA)-positive myeloma: report of four cases. Blut 58: 229–233

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kubota, K., Kurabayashi, H., Kawada, E. et al. Nonsecretion of myeloma protein in spite of an increase in tumor burden by chemotherapy. Ann Hematol 63, 232–233 (1991). https://doi.org/10.1007/BF01703451

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01703451

Key words

Navigation